Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition-Reference-Cited by-同舟云学术

Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition

Published:2009-10-13 Issue:2 Volume:24 Page:548-559
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Chakrabarty Paramita¹,Jansen‐West Karen¹,Beccard Amanda¹,Ceballos‐Diaz Carolina¹,Levites Yona¹,Verbeeck Christophe¹,Zubair Abba C.²,Dickson Dennis¹,Golde Todd E.¹,Das Pritam¹

Affiliation:

1. Department of NeuroscienceMayo ClinicJacksonvilleFloridaUSA

2. Department of Laboratory Medicine and PathologyMayo ClinicJacksonvilleFloridaUSA

Funder

Mayo Clinic

American Health Assistance Foundation

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.09-141754

Reference50 articles.

1. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?;Wyss‐Coray T.;Nat. Med.,2006

2. Inflammation and Alzheimer's disease

3. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex

4. Glial-Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression

5. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease

Cited by 276 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study;Translational Psychiatry;2024-09-09

2. Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease;Cell Reports Medicine;2024-08

3. Neuro-inflammatory Responses in Alzheimer’s v/s Parkinson’s Diseases;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

4. Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases;Fluids and Barriers of the CNS;2024-07-19

5. The Therapeutic Potential of Dalbergia pinnata (Lour.) Prain Essential Oil in Alzheimer’s Disease: EEG Signal Analysis In Vivo, SH-SY5Y Cell Model In Vitro, and Network Pharmacology;Biology;2024-07-18